Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 4Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6Liver Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Turcot syndrome 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Meningioma 1Lung Neoplasms 1Liver Diseases 1Hepatocellular Carcinoma Non-resectable 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Endometrioid 1

Interventions

Colonoscopy 44Standard of Care 28Early Intervention, Educational 23Methods 22Blood Specimen Collection 21Exercise 20Educational Status 19Interviews as Topic 13Surveys and Questionnaires 12Patient Navigation 12Counseling 12Practice Guidelines as Topic 11Endoscopic Mucosal Resection 10Drug Therapy 10Oxaliplatin 9Irinotecan 8Fluorouracil 8Surgical Procedures, Operative 7Preoperative Exercise 7Lidocaine 7Bevacizumab 7Therapeutics 6Resistance Training 6Occult Blood 6Narrow Band Imaging 6Mass Screening 6Leucovorin 6Diet 6Decision Support Techniques 6Control Groups 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Colorectal Neoplasms × sintilimab × Clear all
NCT06456515 2025-02-17

Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC

The First People's Hospital of Changzhou

Phase NA Recruiting
30 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡